Join Model N to learn the trends shaping the future of the medical device industry
REDWOOD CITY, Calif. – February 15, 2016 – Model N, Inc. (NYSE: MODN), the leading provider of cloud-based Revenue Management solutions to life science, technology and manufacturing companies, announces its platinum sponsorship for the 3rd Annual Medical Device Commercial Leaders Forum. The Forum is being held 16-18th February 2016 at the Hotel Bloom in Brussels, Belgium.
“I am excited to have Model N as a platinum sponsor for the 3rd Annual Medical Device Commercial Leaders Forum,” said Geoff Cable, CEO, NextLevelPharma. “They are a well-recognized thought leader in pricing and profit optimization for the Medical Device industry. As well as their exemplary enterprise Configure, Price and Quote software solution – Revvy CPQ, Model N provides insights which help companies maximize revenues and margins. Their expertise will absolutely help meet the needs of med tech executives attending the conference.”
Model N brings deep thought leadership and industry expertise with a top-tier medical device roster, including Johnson & Johnson, Orthoclinical Diagnostics and Boston Scientific. During the forum, Model N will share industry trends and best practices that are reshaping selling and pricing in MedTech. Model N will also be on hand to illustrate their Revenue Management solutions including Configure, Price and Quote (CPQ) for MedTech, the only enterprise solution on the Salesforce1 Platform, that gives sales team a faster, more efficient way to quote, respond to RFPs and generate contracts to maximize profit, grow sales and counter margin erosion.
“We are excited to sponsor the forum and share Model N’s insights into industry trends,” says Peter Zimmerman, Director, Model N. “There are significant changes in buyer mentality that are reshaping the medical device industry. We look forward to sharing our most recent survey findings with attendees and ways to prepare for the future of the industry.”
At the forum, Model N will review the findings from the recent MedTech survey conducted with Value Vantage Partners’ Chris Provines. Six buyer trends are revealed showing more sophisticated buyers and an evolving supply ecosystem. These trends serve as a guide to those in the industry and highlights actions to consider by MedTech companies in preparation.
Please join Model N on February 17 at 09:10 for a presentation on the “Six Buyer Trends Reshaping MedTech Selling & Pricing” or stop by Stand #2 for more information.
About Model N
Model N is the leader in Revenue Management Cloud solutions for life science, technology and manufacturing companies. Driving mission critical business processes such as configure, price and quote (CPQ), contract management, rebates and regulatory compliance, Model N Cloud solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the unique business needs of the world’s leading brands in life science, technology and manufacturing across more than 100 countries. Model N is a trusted partner to some of the world’s largest brands, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Ortho Clinical Diagnostics, Atmel, Fairchild and Marvell. Model N trades on the New York Stock Exchange under the symbol MODN. Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.
+1 (650) 610-4667